Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Plenary Session

Clinical Science
General Topic: Clinical Science

28T01: Plenary III (1722–1727)

Tuesday, October 28, 2025
8:00 AM - 9:30 AM Central Time
Location: W375B
CE: 0.00

Non-CME In Person On Demand

    Abstract Moderator(s)

  • Janet Pope, MD, FRCPC, MPH

    University of Western Ontario
    London, Ontario, Canada

    Disclosure information not submitted.

  • BB

    Betsy Barnes, PhD

    Northwell Health
    Manhasset, New York, United States

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

  • 8:00 AM - 8:15 AM Central Time
    Defining Safe Hydroxychloroquine Blood Levels: Time to Switch to Precision Monitoring for Optimized Lupus Care

    Presenting Author: Shivani Garg, MD, PhD – University of Madison, School of Medicine and Public Health

  • 8:15 AM - 8:30 AM Central Time
    Impaired Maintenance of X-Chromosome Inactivation in B Cells, But Not T Cells, Exacerbates Interferon-Driven Systemic Autoimmunity

    Presenting Author: Nikhil Jiwrajka, MD, MS – University of Pennsylvania

  • 8:30 AM - 8:45 AM Central Time
    Pathogenic role of Mucosal-Associated Invariant T cells in Rheumatoid Arthritis.

    Presenting Author: Manon Lesturgie-Talarek, MD (she/her/hers) – Paris University

  • 8:45 AM - 9:00 AM Central Time
    Functional NOTCH4 Variants Drive Vasculopathy and Fibrosis in Systemic Sclerosis.

    Presenting Author: Urvashi Kaundal, PhD – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)

  • 9:00 AM - 9:15 AM Central Time
    Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies

    Presenting Author: Hu Zeng, PhD – Mayo Clinic

  • 9:15 AM - 9:30 AM Central Time
    Distribution of Fracture Risk Status and Osteoporosis Treatment Use Among Postmenopausal Women with Osteoporosis in the United States

    Presenting Author: Mary Oates, MD – Amgen